Qudos Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 102.30%
- Profit Growth -7.22%
- Ebitda 35.48%
- Net Worth -243.06%
- Total Assets 23.80%
About Qudos Life Sciences
Qudos Life Sciences Private Limited (QLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 April 2018 (Six years and nine months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Minhajul Khan and Kailash Chand serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018PTC332189
-
Company No.
332189
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Apr 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Qudos Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailash Chand
|
Director | 25-Nov-2020 | Current |
|
Minhajul Khan
|
Director | 09-Apr-2018 | Current |
Financial Performance of Qudos Life Sciences.
Qudos Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 102.3% increase. The company also saw a slight decrease in profitability, with a 7.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 243.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qudos Life Sciences?
Unlock access to Qudos Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Mayusha Healthcare Private LimitedMinhajul Khan is a mutual person
-
Maxvantage Private Limited
Kailash Chand is a mutual person
-
Orange Door Communications Private Limited
Kailash Chand is a mutual person
-
Moon Peak Hospitality Private Limited
Kailash Chand is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Qudos Life Sciences?
Unlock and access historical data on people associated with Qudos Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qudos Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qudos Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
